Medical Polymers Market Trends, Opportunities, Key Players, Growth Factors, Revenue Analysis, 2024-2035
For strategic planning and risk management, we have proposed a DELT analysis that can be applied within the Industry.
DELT analysis is an analytical framework that is used to evaluate the environment in which an organization operates / wishes to enter. The analysis is used to review strategic planning processes which can aid the organization to mitigate the upcoming risks. In addition, the analysis can be deployed to invent strategies that can influence financing decisions in order to increase profitability. The primary purpose of this analysis is to develop a better understanding of the offerings of different pharmaceutical polymer / medical polymer manufacturers and establish an understanding of the current industry benchmark.
The pharmaceutical polymers / medical polymers market is expected to grow at a CAGR of around 7.5%, during 2023-2035.
Driven by the ongoing pace of efforts for the development of novel and economical medical-grade polymers, the market is anticipated to witness a steady growth in the coming decade. Our estimates suggest that, in 2023, the maximum revenue generated in this domain is likely to be driven by thermoplastic polymers; this trend is unlikely to change in the foreseen future as well.
Presently, the majority share (48%) of the sales revenues is generated by polymers being used in the development of medical devices, followed by polymers being used as excipients in drug formulations (23%). It is worth mentioning that, in 2023, North America and Europe are likely to capture around 80% of the overall share in this domain. Further, the market in Asia-Pacific is anticipated to grow at a relatively faster pace (9.2%), during the given period.
The increasing traction in the field of pharmaceutical polymers / medical polymers is evident from number of partnerships inked between stakeholder companies in the recent past. The maximum number of partnerships in the pharmaceutical / medical polymers domain were recorded in 2020 and 2022 (12 each). Product development agreements emerged as a prominent type of partnership model being adopted by stakeholders engaged in this domain.
In terms of intercontinental collaborations, maximum number of deals (23%) were signed between companies based in Europe and North America. Further, the maximum number of local as well as international agreements have been signed by companies based in the US.
Pharmaceutical / Medical Polymers: Versatile Materials in the Healthcare Domain
Polymers are materials consisting of repetitive units of monomers that are bound together by strong covalent bonds. They are ubiquitous in our daily lives due to their favorable characteristics. Polymers can be divided into various categories, based on their backbone chain, degradation ability, molecular forces, source of origin, structure of monomer chain and morphology. Further, polymers are being employed in the pharmaceutical / medical sector for a myriad of applications, such as pharmaceutical excipients, medical devices (components and coatings), packaging systems for medications, tissue engineering and 3D printing.
It is important to mention that the manufacturing of pharmaceutical / medical polymers needs to be carried out in a controlled environment with strict adherence to regulatory guidelines in order to maintain the product quality and performance. A variety of novel polymers have also been developed that respond to external stimulus (electric or magnetic field, enzymes, pH, temperature and ultrasound waves), thereby modifying the release of the medication from the dosage form are targeting specific areas in the body. In addition, technological advancements in this domain have led to the development of biodegradable polymers; these polymers are resorbed in the body after fulfilling their function.
Driven by the rising demand for novel medical therapeutics and devices, and the ongoing efforts for the development of pharmaceutical polymers / medical polymers having improved biocompatibility and functionality, we believe that the pharmaceutical polymers / medical polymers market is likely to witness a steady growth over the coming years.
Key Companies Profiled
• Americhem
• Borealis
• Celanese
• Corel Pharma Chem
• Eastman
• Henkel
• KRAIBURG TPE
• Kuraray
• Lubrizol Life Science
• LyondellBasell
To view more details on this report, click on the link
https://www.rootsanalysis.com/reports/medical-polymers-market.html Medical Polymers Market Trends, Opportunities, Key Players, Growth Factors, Revenue Analysis, 2024-2035
For strategic planning and risk management, we have proposed a DELT analysis that can be applied within the Industry.
DELT analysis is an analytical framework that is used to evaluate the environment in which an organization operates / wishes to enter. The analysis is used to review strategic planning processes which can aid the organization to mitigate the upcoming risks. In addition, the analysis can be deployed to invent strategies that can influence financing decisions in order to increase profitability. The primary purpose of this analysis is to develop a better understanding of the offerings of different pharmaceutical polymer / medical polymer manufacturers and establish an understanding of the current industry benchmark.
The pharmaceutical polymers / medical polymers market is expected to grow at a CAGR of around 7.5%, during 2023-2035.
Driven by the ongoing pace of efforts for the development of novel and economical medical-grade polymers, the market is anticipated to witness a steady growth in the coming decade. Our estimates suggest that, in 2023, the maximum revenue generated in this domain is likely to be driven by thermoplastic polymers; this trend is unlikely to change in the foreseen future as well.
Presently, the majority share (48%) of the sales revenues is generated by polymers being used in the development of medical devices, followed by polymers being used as excipients in drug formulations (23%). It is worth mentioning that, in 2023, North America and Europe are likely to capture around 80% of the overall share in this domain. Further, the market in Asia-Pacific is anticipated to grow at a relatively faster pace (9.2%), during the given period.
The increasing traction in the field of pharmaceutical polymers / medical polymers is evident from number of partnerships inked between stakeholder companies in the recent past. The maximum number of partnerships in the pharmaceutical / medical polymers domain were recorded in 2020 and 2022 (12 each). Product development agreements emerged as a prominent type of partnership model being adopted by stakeholders engaged in this domain.
In terms of intercontinental collaborations, maximum number of deals (23%) were signed between companies based in Europe and North America. Further, the maximum number of local as well as international agreements have been signed by companies based in the US.
Pharmaceutical / Medical Polymers: Versatile Materials in the Healthcare Domain
Polymers are materials consisting of repetitive units of monomers that are bound together by strong covalent bonds. They are ubiquitous in our daily lives due to their favorable characteristics. Polymers can be divided into various categories, based on their backbone chain, degradation ability, molecular forces, source of origin, structure of monomer chain and morphology. Further, polymers are being employed in the pharmaceutical / medical sector for a myriad of applications, such as pharmaceutical excipients, medical devices (components and coatings), packaging systems for medications, tissue engineering and 3D printing.
It is important to mention that the manufacturing of pharmaceutical / medical polymers needs to be carried out in a controlled environment with strict adherence to regulatory guidelines in order to maintain the product quality and performance. A variety of novel polymers have also been developed that respond to external stimulus (electric or magnetic field, enzymes, pH, temperature and ultrasound waves), thereby modifying the release of the medication from the dosage form are targeting specific areas in the body. In addition, technological advancements in this domain have led to the development of biodegradable polymers; these polymers are resorbed in the body after fulfilling their function.
Driven by the rising demand for novel medical therapeutics and devices, and the ongoing efforts for the development of pharmaceutical polymers / medical polymers having improved biocompatibility and functionality, we believe that the pharmaceutical polymers / medical polymers market is likely to witness a steady growth over the coming years.
Key Companies Profiled
• Americhem
• Borealis
• Celanese
• Corel Pharma Chem
• Eastman
• Henkel
• KRAIBURG TPE
• Kuraray
• Lubrizol Life Science
• LyondellBasell
To view more details on this report, click on the link
https://www.rootsanalysis.com/reports/medical-polymers-market.html
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek